CClinicalTrials.gg
CompletedNCT06754137FAIRUpdated Aug 17, 2026

AI-Assisted Fracture Detection in Emergency Radiography

An interventional study of BoneView AI-Assisted Radiograph Interpretation in Bone Fractures, sponsored by Salzburger Landeskliniken. Completed at 3 sites in 2 countries. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Salzburger Landeskliniken · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
1,667
Allocation
Randomized
Ages
2 Years and older
Sex
All
01

Study summary

This study evaluates whether artificial intelligence (AI) can support doctors who interpret X-rays for suspected fractures in emergency care.

In the participating hospitals, X-rays are usually interpreted first by the frontline treating physician, while the formal radiology report is generally available later and not before the patient leaves the emergency department. AI may therefore provide an immediate additional assessment while clinical decisions are being made.

Patients were randomly assigned to one of two groups. In the AI-assisted group, physicians interpreted the X-rays with support from an AI system. In the control group, physicians interpreted the same type of X-rays without AI support. All final diagnoses and treatment decisions remained with the treating physician.

The main question is whether AI assistance affects the time from triage to completion of emergency department treatment. The study also evaluates whether AI influences physician diagnostic confidence, the use of additional imaging, missed fractures, and diagnostic accuracy.

The study includes patients aged 2 years or older presenting after trauma with a suspected fracture requiring X-ray imaging. No additional imaging or treatment was required solely because of study participation.

Read the detailed description

The FAIR (Fracture detection with AI in emergency Radiography) Trial is a prospective, international, multicentre, pragmatic randomized controlled trial evaluating the clinical impact of AI-assisted interpretation of emergency radiographs.

The study was conducted at three hospitals in Austria and Germany: University Hospital Salzburg, Regional Hospital Hallein, and University Hospital Nuremberg.

Clinical setting

In the participating departments, plain radiographs of patients with suspected fractures are routinely interpreted by frontline orthopaedic trauma or paediatric physicians, who make immediate diagnostic and treatment decisions. Formal radiology reports are generally available later and are usually not available before completion of the emergency department encounter.

The study therefore evaluates AI as an immediate diagnostic decision-support tool during the period in which frontline physicians make clinical decisions, rather than as a replacement for formal radiological interpretation.

Study design

Eligible patient encounters were randomized in a 1:1 ratio to one of two parallel groups:

Control group: radiographs were interpreted by the treating physician without access to AI output.

AI-assisted group: radiographs were interpreted by the treating physician with access to real-time AI output.

The randomization sequence was generated by the trial statistician as one global sequence. Allocation was concealed during recruitment using folded sequential study forms on which only the study number was visible on the front and the treatment allocation was printed on the reverse. Allocation was revealed after radiography, when the triage nurse opened the study form and directed the patient to the corresponding treatment pathway.

All final diagnoses, decisions regarding additional imaging, treatment decisions, and discharge decisions remained the responsibility of the treating physician.

AI intervention

The AI system used was BoneView version 2.3.8 (Gleamer, Paris, France). BoneView analyzes DICOM radiographs and provides visual annotations and classifications for supported musculoskeletal findings.

In addition to fracture-related findings, other BoneView outputs supported by the system, including dislocations, joint effusions, and focal bone lesions, could be visible to physicians in the AI-assisted group. However, the main clinical outcomes of the FAIR Trial focus on fracture-related emergency care.

At University Hospital Salzburg and Regional Hospital Hallein, BoneView was provided through the Aidoc aiOS platform. At University Hospital Nuremberg, BoneView was integrated directly into the local imaging workflow.

Participating physicians received standardized onboarding consisting of a lecture and practical demonstration of the AI system before study implementation.

Study population

Patients were eligible if they were aged 2 years or older, presented after trauma with a suspected fracture requiring plain radiography, and had an injury involving a single anatomical region within the supported scope of the AI system.

Major exclusions included injuries involving multiple anatomical regions, head or cervical spine injuries, previous imaging or medical assessment for the same injury, contraindications to X-ray imaging, and lack of informed consent.

The unit of observation is the patient encounter. The same individual could therefore participate more than once if they presented with separate and unrelated injuries during the study period.

Outcomes

During ongoing recruitment in March 2026, following methodological review and before comparative outcome analysis, the outcome hierarchy was revised to prioritize patient- and physician-centered measures of clinical utility.

The primary outcome is time from triage to completion of emergency department treatment.

Key secondary outcomes include:

physician diagnostic confidence; additional imaging requested during the index emergency department encounter.

Secondary clinical outcomes include:

missed fractures; diagnostic performance compared with an expert-adjudicated reference standard, including sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy.

The originally registered outcome hierarchy placed greater emphasis on diagnostic performance. The registry record was not updated at the time of the March 2026 methodological revision and is being updated retrospectively to reflect the final analysis plan.

Reference standard

The reference standard for whether a fracture was visible on the index radiograph is established through expert review by a senior radiologist and a senior orthopaedic trauma surgeon. Reviewers can use the available imaging and clinical information when adjudicating each case.

The adjudication specifically determines whether a fracture was visible on the original radiograph. A fracture identified on subsequent CT or other imaging but considered occult on the original radiograph is therefore classified as no fracture visible on the index radiograph.

Disagreements between the two reviewers are resolved by discussion. If consensus cannot be reached, a third expert reviewer determines the final classification.

Study duration

Patient recruitment was conducted during predefined study periods between October 2025 and April 2026. Recruitment ended after completion of the planned site-specific recruitment periods and the available funded period of AI access, rather than because of observed treatment effects.

02

Conditions studied

  • Bone Fractures

Keywords

  • Artificial Intelligence
  • Fracture Detection
  • Emergency Care
  • AI-Assisted Diagnosis
  • Diagnostic Accuracy
  • Orthopedic Diagnostics
  • Emergency Radiography
  • Clinical Decision Support
  • Diagnostic Confidence
  • Emergency Department
03

Who can participate

Ages eligible
2 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 2 years or older.
  • Presentation to the emergency department following trauma requiring plain radiographic imaging.
  • Injury involving a single anatomical region within the supported anatomical scope of the AI system.
  • Written informed consent provided by the participant or legally authorized representative, with age-appropriate assent where applicable.

Exclusion criteria

Exclusion Criteria:

  • Age younger than 2 years.
  • Injuries involving multiple anatomical regions.
  • Head or cervical spine injuries.
  • Previous radiographic imaging or medical assessment for the same injury before the index presentation.
  • Contraindication to X-ray imaging, including pregnancy.
  • Lack of informed consent.

Reduced image quality was not an exclusion criterion. Multiple fractures within the same anatomical injury region were eligible.

04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,667 participants (actual)

Study arms

  • No intervention
    Standard Radiograph Interpretation Without AI

    Plain radiographs are interpreted by the frontline treating physician according to routine clinical practice without access to AI output. All diagnostic, imaging, treatment, consultation, and discharge decisions remain the responsibility of the treating physician. Formal radiology reports are generally available later and are not routinely available before completion of the emergency department encounter.

  • Experimental
    AI-Assisted Radiograph Interpretation

    Plain radiographs are interpreted by the frontline treating physician with access to real-time output from BoneView version 2.3.8 (Gleamer, Paris, France). The AI output is used as diagnostic decision support only; all final diagnostic, imaging, treatment, consultation, and discharge decisions remain the responsibility of the treating physician.

    Diagnostic Test: BoneView AI-Assisted Radiograph Interpretation

Interventions

  • Diagnostic testBoneView AI-Assisted Radiograph Interpretation

    BoneView version 2.3.8 (Gleamer, Paris, France) analyzes DICOM radiographs and provides real-time visual annotations and classifications for supported musculoskeletal abnormalities. Physicians in the intervention group could view fracture-related findings as well as other supported outputs, including dislocations, joint effusions, and focal bone lesions. At University Hospital Salzburg and Regional Hospital Hallein, BoneView was delivered through the Aidoc aiOS platform (version 3.24.0). At University Hospital Nuremberg, BoneView was integrated directly into the local imaging workflow. BoneView was used as a decision-support tool and did not replace physician interpretation or the subsequent formal radiology report.

05

What researchers measure

Primary outcomes

  1. Diagnostic Accuracy of Fracture/Dislocation/Effusion/Bone Lesion Detection

    The primary outcome measures the diagnostic accuracy of detecting broken bones/dislocations/effusions/bone lesions using sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC). Diagnostic accuracy will be compared between the AI-assisted diagnostic approach and the standard physician-only approach. The gold standard for comparison will be determined by expert consensus based on independent review by a radiologist and an orthopedic specialist.

    Time frame: At the time of initial diagnosis, within 2 hours of patient presentation to the orthopedic emergency unit

Secondary outcomes

  1. Time to Diagnosis

    The time required to establish a diagnosis, measured from the moment the patient undergoes X-ray imaging to the time the final diagnosis is recorded. This will compare the efficiency of the AI-assisted diagnostic workflow with the standard physician-only workflow.

    Time frame: During the patient's emergency department visit, typically within 4 hours of presentation.

  2. Physician Diagnostic Confidence

    The level of confidence reported by physicians in their diagnostic decisions, measured on a Likert scale (1-10). This will compare how confident physicians feel when using AI assistance versus relying solely on their expertise.

    Time frame: Measured immediately after the diagnosis

06

Study locations

3 sites
  • Landesklinik Hallein, Salzburger Landeskliniken
    Hallein, 5400, Austria
  • University Hospital Salzburg, Salzburger Landeskliniken
    Salzburg, 5020, Austria
  • University Hosptial Nuremberg, Klinikum Nürnberg
    Nuremberg, 90471, Germany
07

References and documents

Publications

  • Breitwieser M, Zirknitzer S, Poslusny K, Freude T, Scholsching J, Bodenschatz K, Wagner A, Hergan K, Schaffert M, Metzger R, Marko P. AI in Fracture Detection: A Cross-Disciplinary Analysis of Physician Acceptance Using the UTAUT Model. Diagnostics (Basel). 2025 Aug 21;15(16):2117. doi: 10.3390/diagnostics15162117. PubMed 40870969 ↗

Study documents

  • Protocol and statistical analysis plan · May 5, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in the primary publication will be made available to qualified researchers upon reasonable written request. Shared data may include participant demographics, anatomical injury region, frontline physician diagnosis, AI findings, expert-adjudicated reference-standard findings, diagnostic confidence, additional imaging, and timing data used to derive the primary endpoint. Data will be shared only for scientifically justified research purposes following review and approval of the proposed project by the study investigators and execution of an appropriate data-sharing agreement. Data sharing will comply with applicable institutional requirements, the General Data Protection Regulation (GDPR), and relevant Austrian and German data-protection legislation.

08

Registry details

Key details

Study ID
NCT06754137
Lead sponsor
Salzburger Landeskliniken
Collaborators
Klinikum Nürnberg
Responsible party
Martin Breitwieser (Principal Investigator, Salzburger Landeskliniken) — Principal investigator
First posted
Dec 31, 2024
Start date
Oct 1, 2025
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026
Last update
Aug 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion